Paxlovid (Drug)

Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers Report

But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last.

By Pam Belluck

Drugs (Pharmaceuticals) Elderly National Institutes of Health Paxlovid (Drug) Pfizer Inc Research United States

Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.

With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.

By Christina Jewett

Coronavirus (2019-nCoV) Elder Care Elderly Journal of the American Medical Assn Nursing Homes Paxlovid (Drug) Protective Clothing and Gear Research Tests (Medical)

How Nursing Homes Failed to Protect Residents From Covid

A series of hurdles prevented the facilities from shielding older people, despite the best efforts of staff. Experts are calling for reforms before the next virus arrives.

By Paula Span

Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Food and Drug Administration Paxlovid (Drug) Pfizer Inc United States

F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment

While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.

By Carl Zimmer and Christina Jewett